ArticleInternational urology and nephrology2025

Efficacy and safety of neoadjuvant chemohormonal therapy for high-risk prostate cancer treated with robot-assisted laparoscopic radical prostatectomy: a propensity score-matched analysis (the MSUG94 group).

Yuki Yokoyama et al.PubMed ↗Publisher ↗

No numbers read from the abstract.